(J Histochem
Cytochem 37: [1503] [1504] [1505] [1506] [1507] [1508] 1989) was identical to that known from the literature. ..
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Results
The influence offixation and decalcification on tissue osteocalcin is shown in 8 and 9 ). In the preexisting lamellam bone trabeculae, osteocalcin was clearly detectable in osteocytes and along the lamellam bone matrix in fine granular deposits.
Theme was also some immunoreactivity in the stmoma bordering the tumor cells ( Figure  8 ).
Primary
Bone-forming Tumors.
Five cases of bone-forming neoplasms were studied, two osteoid osteomas and three osteogenic sarcomas. One osteoid osteoma showed strong immunoreactivity for osteocalcin in osteoblasts in the nidus ( Figure  10 ) and in -the surrounding bone tmabeculae, as well in bone matrix and in the vascular stmoma of the nidus. In the other case of osteoid osteoma, only weak osteocalcin immunoreactivity was visible in the matrix of the surrounding lamellar sclerotic bone.
Of the three cases of osteogenic sarcoma, one specimen showed strong but heterogeneous osteocalcin immunomeactivity in tumor cells but not in the tumor bone matrix ( Figure  11 ). In another case, weak expression in the tumor cells was observed, while in the third case osteocalcin immunoreactivity could not be detected.
Discussion
In recent years, increasing attention has been paid to osteocalcin, a small protein which constitutes between 10-20% of the noncollagenous organic material of bone matrix (1). Despite detailed knowledge concerning the biochemistry of the molecule and the well-established fact that it has a high affinity for hydmoxyapatite crystals (2), the function ofosteocalcin has not yet been elucidated. In vitro studies of mat and human osteosarcoma cells have shown that the protein is produced in osteoblastic cells (8, 9) 
